Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-20

FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Children's Allegra Allergy (fexofenadine hydrochloride) to support labeling for pediatric use, expanding indications…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CHILDRENS ALLEGRA ALLERGY (FEXOFENADINE HYDROCHLORIDE)

Snippet

SUPPL AP for CHILDRENS ALLEGRA ALLERGY (FEXOFENADINE HYDROCHLORIDE)